What is Novoeight®?
Novoeight® (antihemophilic factor, recombinant) is an injectable medicine used to control and prevent bleeding in people with hemophilia A. Your healthcare provider may give you Novoeight when you have surgery

• Novoeight® is not used to treat von Willebrand Disease

Important Safety Information

Who should not use Novoeight®?
You should not use Novoeight® if you are allergic to factor VIII or any of the other ingredients of Novoeight® or if you are allergic to hamster proteins

What is the most important information I need to know about Novoeight®?

• Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia center
• Call your healthcare provider right away and stop treatment if you get any of the following signs of an allergic reaction: rashes or hives, difficulty breathing or swallowing, tightness of the chest, swelling of the lips and tongue, light-headedness, dizziness or loss of consciousness, pale and cold skin, fast heartbeat, or red or swollen face or hands

What should I tell my healthcare provider before using Novoeight®?

• Before taking Novoeight®, you should tell your healthcare provider if you have or have had any medical conditions, take any medicines (including non-prescription medicines and dietary supplements), are nursing, pregnant or planning to become pregnant, or have been told that you have inhibitors to factor VIII
• Your body can make antibodies called “inhibitors” against Novoeight®, which may stop Novoeight® from working properly. Call your healthcare provider right away if your bleeding does not stop after taking Novoeight®

What are the possible side effects of Novoeight®?

• Common side effects of Novoeight® include inhibitors in patients who were not previously treated with factor VIII products, swelling or itching at the location of injection, and fever.

Novoeight® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Is it time to reconsider your treatment? Check the standard half-life rFVIII Comparison Guide.

The above table is not intended to compare the safety or efficacy of any of the product.
aData current as of July 22, 2020.

Portable, reliable, and effective.
Novoeight® is designed to fit into your life. It has the storage flexibility you need to stay on the go, and studies show that it’s reliable.

Get a higher degree of portability.
Now you can choose a treatment that’s ready to go when you are.

The ONLY standard half-life (SHL) rFVIII with stability up to 104˚F for up to 3 months.a

rFVIII=recombinant factor VIII.
aCompared with other recombinant FVIII products.

Store Novoeight® at up to 104˚F for up to 3 months or up to 86˚F for up to 12 months.
Temperature storage
 
Temperature storage
Novoeight® offers the highest storage temperature after reconstitution of any standard half-life product—104˚F.a Plus, the longest room temperature storage time after reconstitution of any standard half-life product—4 hours at up to 86˚F.

Write a review